OPRL1 and neoplasm: In these B cell–depleted mice, OPRL1 antagonism (SB612111) no longer influenced tumor growth, nociceptive behavior, or CGRP levels (Fig. 7C–E), indicating that B-cells are crucial for the antinociceptive and anti-tumor effects of N/OFQ.